CID 91754477

Cevidoplenib

Structural Information

Molecular Formula
C25H27N7O3
SMILES
CC1=NN(C=C1CN2C[C@@H](CO2)O)C3=NC(=NC=C3)NC4=CC5=C(C=C4)N(C=C5C(=O)C6CC6)C
InChI
InChI=1S/C25H27N7O3/c1-15-17(10-31-12-19(33)14-35-31)11-32(29-15)23-7-8-26-25(28-23)27-18-5-6-22-20(9-18)21(13-30(22)2)24(34)16-3-4-16/h5-9,11,13,16,19,33H,3-4,10,12,14H2,1-2H3,(H,26,27,28)/t19-/m0/s1
InChIKey
YCZUBLQESBVOSH-IBGZPJMESA-N
Compound name
cyclopropyl-[5-[[4-[4-[[(4S)-4-hydroxy-1,2-oxazolidin-2-yl]methyl]-3-methylpyrazol-1-yl]pyrimidin-2-yl]amino]-1-methylindol-3-yl]methanone
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

1
References

21
Patents

473.21753 Da
Monoisotopic Mass

2.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 474.22481 213.4
[M+Na]+ 496.20675 228.2
[M+NH4]+ 491.25135 218.4
[M+K]+ 512.18069 229.3
[M-H]- 472.21025 226.3
[M+Na-2H]- 494.19220 221.4
[M]+ 473.21698 220.2
[M]- 473.21808 220.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe